MDMB-5'Br-BUTINACA

MDMB-5'Br-BUTINACA

Structure of MDMB-5'Br-BUTINACA

MDMB-5'Br-BUTINACA is a synthetic cannabinoid that has been identified as a designer drug. It is part of the indazole-3-carboxamide family and is known for its potent agonistic activity at the cannabinoid receptors, particularly the CB1 receptor. This compound has been encountered in various synthetic cannabis products, often marketed as "legal highs" or "herbal incense."

Chemical Structure and Properties

MDMB-5'Br-BUTINACA is chemically classified as an indazole-based synthetic cannabinoid. Its full chemical name is methyl 2-[[1-(5-bromo-1-methyl-1H-indazole-3-carbonyl)azetidin-3-yl]amino]-3-methylbutanoate. The presence of a bromine atom at the 5' position of the indazole ring is a distinctive feature of this compound, which may influence its binding affinity and activity at cannabinoid receptors.

The compound is typically synthesized in clandestine laboratories and is often found in powder form, which is then dissolved and sprayed onto plant material to be smoked or vaporized by users.

Pharmacology

MDMB-5'Br-BUTINACA acts as a potent agonist at the CB1 receptor, which is primarily responsible for the psychoactive effects associated with cannabinoids. The activation of CB1 receptors by synthetic cannabinoids like MDMB-5'Br-BUTINACA can lead to a range of effects, including euphoria, altered perception, and relaxation. However, these compounds can also cause adverse effects such as anxiety, paranoia, and in some cases, severe toxicity.

The pharmacokinetics of MDMB-5'Br-BUTINACA, including its metabolism and excretion, are not well-documented, but it is believed to undergo similar metabolic pathways as other synthetic cannabinoids, involving hydroxylation and carboxylation.

Legal Status

Due to its potential for abuse and adverse health effects, MDMB-5'Br-BUTINACA has been subject to legal control in several countries. It is often classified as a controlled substance, making its manufacture, distribution, and possession illegal without proper authorization.

Health Risks and Toxicity

The use of MDMB-5'Br-BUTINACA has been associated with numerous health risks. Users may experience acute intoxication, which can manifest as confusion, agitation, hallucinations, and cardiovascular effects such as tachycardia and hypertension. In severe cases, it can lead to seizures, renal failure, and even death.

The variability in the potency and composition of synthetic cannabinoid products makes them particularly dangerous, as users may inadvertently consume higher doses than intended.

Related Pages

• Synthetic cannabinoids
• Cannabinoid receptor
• Designer drug
• Drug policy